Targeting the proteasome as a therapeutic strategy against haematological malignancies

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.2, 2006-02, pp. : 117-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IAPs as therapeutic targets in haematological malignancies

By Langemeijer SMC de Graaf AO Jansen JH

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 981-993

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 573-578

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1341-1347

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M Chiarini Francesca Evangelisti Camilla Ognibene Andrea Bressanin Daniela Billi Anna Maria Manzoli Lucia Cappellini Alessandra McCubrey James A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?

Current Medicinal Chemistry, Vol. 23, Iss. 22, 2016-07 ,pp. : 2350-2362

Bentham Science Publishers

Access to resources Recommend Favorite